A detailed history of American Portfolios Advisors transactions in Bionano Genomics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 2,926 shares of BNGO stock, worth $1,989. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,926
Holding current value
$1,989
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$0.36 - $2.86 $1,053 - $8,368
2,926 New
2,926 $5.36 Million
Q1 2022

Mar 21, 2023

BUY
N/A
1,242 Added 42.45%
4,168 $10.8 Million
Q4 2021

Mar 21, 2023

BUY
N/A
1,242 Added 42.45%
4,168 $12.5 Million
Q3 2021

Mar 22, 2023

BUY
N/A
278 Added 9.5%
3,204 $17.6 Million
Q2 2021

Mar 22, 2023

BUY
N/A
78 Added 2.67%
3,004 $22 Million
Q1 2021

Mar 22, 2023

SELL
N/A
-1,334 Reduced 45.59%
1,592 $12.9 Million
Q4 2020

Mar 22, 2023

SELL
N/A
-426 Reduced 14.56%
2,500 $7.7 Million

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $197M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.